Temecula, CA, United States of America

Patrick A Schneider

This inventor holds 3 USPTO granted patents. Top assignees: Reprogen, Inc., Diagnostic Products Corporation. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick A Schneider. Retrieved from https://idiyas.com/inventor/patrick-a-schneider-6bfxsip2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • Irvine, CA (US) (2001 - 2002)
  • Temecula, CA (US) (2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Patrick A Schneider

Introduction

Patrick A Schneider is an accomplished inventor based in Temecula, CA. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning endometriosis. With a total of 3 patents to his name, Schneider's work has the potential to impact many lives.

Latest Patents

One of Schneider's latest patents focuses on the use of prothymosin in the diagnosis and treatment of endometriosis. His research indicates that prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods for diagnosing endometriosis by detecting the up-regulation of a prothymosin gene product. Additionally, it offers methods for treating endometriosis by down-regulating the expression of prothymosin in ectopic or eutopic endometriotic tissue.

Another significant patent by Schneider involves the use of cathepsin S in the diagnosis and treatment of endometriosis. Similar to his previous work, he found that cathepsin S expression is also up-regulated in endometriotic tissue. This invention provides methods for diagnosing endometriosis by detecting the up-regulation of a cathepsin S gene product. Furthermore, it presents methods for treating endometriosis by down-regulating the expression of cathepsin S in ectopic or eutopic endometriotic tissue.

Career Highlights

Throughout his career, Patrick A Schneider has worked with notable companies such as Reprogen, Inc. and Diagnostic Products Corporation. His experience in these organizations has contributed to his expertise in medical diagnostics and treatment innovations.

Collaborations

Some of Schneider's coworkers include Cynthia K French and Karen K Yamamoto. Their collaboration has likely played a role in advancing his research and patent developments.

Conclusion

Patrick A Schneider's innovative work in the field of endometriosis diagnosis and treatment showcases his dedication to improving medical science. His patents reflect a commitment to addressing significant health issues, and his contributions are poised to make a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…